These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 14574807
1. [Diagnostic value of complexed prostate-specific antigen for prostate cancer]. Su HW, Li Y, Xu P. Zhonghua Nan Ke Xue; 2003 Sep; 9(6):431-3. PubMed ID: 14574807 [Abstract] [Full Text] [Related]
2. Accurate cut-off point for free to total prostate-specific antigen ratio used to improve differentiation of prostate cancer from benign prostate hyperplasia in Iranian population. Amirrasouli H, Kazerouni F, Sanadizade M, Sanadizade J, Kamalian N, Jalali M, Rahbar K, Karimi K. Urol J; 2010 Jun 10; 7(2):99-104. PubMed ID: 20535696 [Abstract] [Full Text] [Related]
3. [Measurement and analysis of different serum PSA in patients with benign prostatic hyperplasia]. Li Y, Xu P, Zhang PA, Su HW, Zhang J. Zhonghua Nan Ke Xue; 2003 Aug 10; 9(5):361-3, 366. PubMed ID: 14513646 [Abstract] [Full Text] [Related]
4. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms. Filella X, Truan D, Alcover J, Quintó L, Molina R, Luque P, Coca F, Ballesta AM. Urology; 2004 Jun 10; 63(6):1100-3; discussion 1103-4. PubMed ID: 15183958 [Abstract] [Full Text] [Related]
5. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together. Serdar MA, Oguz O, Olgun A, Seçkin B, Ilgan S, Hasimi A, Salih M, Peker F, Kutluay T. Ann Clin Lab Sci; 2002 Jun 10; 32(1):22-30. PubMed ID: 11848613 [Abstract] [Full Text] [Related]
6. Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial. Partin AW, Brawer MK, Bartsch G, Horninger W, Taneja SS, Lepor H, Babaian R, Childs SJ, Stamey T, Fritsche HA, Sokoll L, Chan DW, Thiel RP, Cheli CD. J Urol; 2003 Nov 10; 170(5):1787-91. PubMed ID: 14532777 [Abstract] [Full Text] [Related]
9. Complexed PSA improves prostate cancer detection: results from a multicenter Japanese clinical trial. Okihara K, Ukimura O, Nakamura T, Ushijima S, Mizutani Y, Kawauchi A, Naya Y, Kojima M, Miki T. Urology; 2006 Feb 10; 67(2):328-32. PubMed ID: 16461082 [Abstract] [Full Text] [Related]
10. Ratio of alpha 1-antichymotrypsin--prostate specific antigen to total prostate specific antigen in prostate cancer diagnosis. Lein M, Jung K, Elgeti U, Brux B, Sinha P, Schnorr D, Loening SA. Anticancer Res; 2000 Feb 10; 20(6D):4997-5001. PubMed ID: 11326657 [Abstract] [Full Text] [Related]
11. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range. Mutlu N, Türkeri LN, Yencilek F, Demir A, Emerk K. Can J Urol; 2009 Apr 10; 16(2):4558-67. PubMed ID: 19364428 [Abstract] [Full Text] [Related]
16. A multicenter clinical trial on the use of alpha1-antichymotrypsin-prostate-specific antigen in prostate cancer diagnosis. Lein M, Jung K, Hammerer P, Graefen M, Semjonow A, Stieber P, Ossendorf M, Luboldt HJ, Brux B, Stephan C, Schnorr D, Loening SA. Prostate; 2001 May 01; 47(2):77-84. PubMed ID: 11340629 [Abstract] [Full Text] [Related]
20. Effect of hemodialysis on serum complexed prostate-specific antigen levels. Tarhan F, Orçun A, Küçükercan I, Camursoy N, Kuyumcuoglu U. Scand J Urol Nephrol; 2007 May 01; 41(5):382-6. PubMed ID: 17853041 [Abstract] [Full Text] [Related] Page: [Next] [New Search]